Ontunisertib

DRUG2 trials

Sponsors

Agomab Spain S.L.U.

Conditions

Fibrostenotic Crohn's Disease

Phase 1

Human Mass Balance Study of [14C] Ontunisertib in Healthy Volunteers

RecruitingNCT07672574

Agomab Spain S.L.U.Fibrostenotic Crohn's Disease

Start: 2026-09-09End: 2026-09-26Target: 8Updated: 2026-09-11

Phase 2

NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease

RecruitingNCT07683325

Agomab Spain S.L.U.Fibrostenotic Crohn's Disease

Start: 2026-10-30End: 2029-06-30Target: 320Updated: 2026-09-11